Trokendi XR topiramate capsules recalled for failed dissolution
Supernus Pharmaceuticals is recalling one lot of Trokendi XR (topiramate extended-release capsules, 25 mg, 30 count) because it failed dissolution specifications. The FDA has classified the recall as Class III, and no injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Talk to your pharmacist or prescriber before stopping it.
- Check whether your bottle is Lot 2075801 with expiration date 31-Oct-2029 (NDC 17772-101-30).
- The notice doesn't say how to get a refund or replacement; contact Supernus Pharmaceuticals or the pharmacy where you bought it.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 15,853 bottles
- Illnesses reported
- None reported
- Manufactured in
- 9715 Key West Ave, N/A, Rockville, MD, United States
- Classification
- Class III
- Recall number
- D-0758-2026
In the FDA's words
- Description
- Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30. Failed Dissolution Specifications Lot # 2075801, Exp Date: 31-Oct-2029. Distribution: US Nationwide. Affected quantity: 15,853 bottles
- Hazard
- Failed Dissolution Specifications
More from Supernus
- Trokendi XR topiramate capsules recalled for failed dissolution
ModerateFDASep 9, 2026